<DOC>
	<DOCNO>NCT02100722</DOCNO>
	<brief_summary>The purpose study determine whether Fractional flow reserve ( FFR , ( coronary pressure wire-based index assess ischemic potential coronary lesion ) -guided percutaneous coronary intervention ( PCI ) patient multivessel coronary artery disease ( CAD ) result similar outcome coronary artery bypass graft surgery ( CABG ) .</brief_summary>
	<brief_title>A Comparison Fractional Flow Reserve-Guided Percutaneous Coronary Intervention Coronary Artery Bypass Graft Surgery Patients With Multivessel Coronary Artery Disease</brief_title>
	<detailed_description>The FAME 3 trial multicenter , international , randomize , control noninferiority trial . All patient multivessel CAD ( involve left main ) screen site 's Heart Team ( include limit interventional cardiologist , cardiac surgeon research coordinator ) . If agree patient treat either FFR-guided PCI CABG , inclusion criterion meet exclusion criterion meet , patient randomize . Baseline clinical , functional , laboratory electrocardiographic data obtain . Patients receive treatment within 4 week randomization . Patients randomized CABG receive state art therapy discretion local surgeon strong emphasis arterial revascularization . Patients undergo PCI FFR measure St. Jude Medical coronary pressure wire across lesion . If FFR ≤0.80 , PCI perform Medtronic Resolute Integrity drug-eluting stent ( DES ) per usual routine . If FFR &gt; 0.80 PCI defer . All patient receive medical therapy per publish guideline . Patients follow-up 1 6 month , 1 3 year evaluation clinical status , functional status , medication event . Follow-up may extend 5 year , funding allows . Core lab analysis include formal quantitative coronary angiography ( QCA ) baseline angiograms calculation Synergy Percutaneous Coronary Intervention Taxus Cardiac Surgery ( SYNTAX ) score Functional SYNTAX Score .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Coronary Stenosis</mesh_term>
	<criteria>1 . Age ≥ 21 year angina and/or evidence myocardial ischemia 2 . Three vessel CAD , define ≥ 50 % diameter stenosis visual estimation three major epicardial vessel major side branch , involve leave main coronary artery , amenable revascularization PCI CABG determine Heart Team . Patients nondominant right coronary artery may include leave anterior descend artery ( LAD ) leave circumflex ≥50 % stenosis 3 . Willing able provide inform , write consent 1 . Requirement cardiac noncardiac surgical procedure ( e.g. , valve replacement , carotid revascularization ) 2 . Cardiogenic shock and/or need mechanical/pharmacologic hemodynamic support 3 . Recent STEMI ( &lt; 5 day prior randomization ) 4 . Ongoing Non STEMI biomarkers ( cardiac troponin ) still rise 5 . Known leave ventricular ejection fraction &lt; 30 % 6 . Life expectancy &lt; 2 year 7 . Requiring renal replacement therapy 8 . Undergoing evaluation organ transplantation 9 . Participation plan participation another clinical trial , except observational registry 10 . Pregnancy 11 . Inability take dual antiplatelet therapy six month 12 . Previous CABG 13 . Left main disease require revascularization 14 . Extremely calcified tortuous vessel preclude FFR measurement 15 . Any target lesion instent drugeluting stent restenosis</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>